Anticoagulant and antiplatelet drugs Flashcards

1
Q

What are some examples of indications for anticoagulant drugs?

A
  • Venous thrombosis
  • Atrial fibrillation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What pathway do anticoagulant drugs target?

A

Fibrin clot formation pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does heparin work and how is it administered?

A
  • Potentiates the effects of anti-thrombin - negative feedback to thrombin and factors VIIa, V, Xa, VIII, XIa and TF
  • Immediate effect
  • Parenteral (IV or SC) 2 forms - unfractionated and low molecular weight (LMWH)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How are patients on heparin monitored?

A
  • Activated partial thromboplastin time (APTT) for unfractionated heparin
  • Anti-Xa assay for LMWH but usually no monitoring of LMWH is required as more predictable repsonse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the potential complications of heparin treatment?

A
  • Bleeding - heparin induced thrombocytopenia (HITT) - monitor FBC in patients on heparin
  • Osteoporosis with long term use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How are the effects of heparin reversed?

A
  • Stop the heparin!
  • Occassionally in severe bleeding - protamine sulphate, reverses antithrombin effect
  • Complete reversal for unfractionated
  • Partial reversal for LMWH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name some examples of coumarin anti-coagulants and describe their mechanism of action

A
  • Drugs - warfarin, phenindione, acenocoumarin, phenprocoumon
  • Mechanism of action - inhibition of vitamin K
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are vitamin K dependent coagulation factors and where are they synthesised?

A
  • Factors II (prothrombin), VII, IX and X - protein C and protein S
  • Synthesised in liver
  • They require vitamin K for final carboxylation step essential for their function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the mechanism of action of warfarin?

A

Acts as an anticoagulant by blocking the ability of vitamin K to carboxylate the vitamin K dependent clotting factors (II, VII, IX + X), thereby reducing their coagulant activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is warfarin therapy given?

A
  • Narrow therapeutic window so need to monitor therapy
  • Maintenance - dose should be taken at same time every day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is INR?

A
  • A mathematical correction for differences in the sensitivity of thromboplastin reagents
  • Allows for comparison of results between labs and standardizes reporting of the prothrombin time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the major adverse effect associated with warfarin and what factors may influence this?

A

Haemorrhage!

Intensity of anti-coagulation, concomitant clinical disorders, concomitant use of other medications, *beware of drug interactions*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some of the bleeding complications associated with warfarin?

A
  • Mild - skin bruising, epistaxis, haematuria
  • Severe - GI, intracerebral, significant drop in Hb
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How are the effects of warfarin reversed?

A

Omit warfarin dose -> administer oral vitamin K -> administer clotting factors (FFP) -> clinical and laboratory assessment of response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How effective are the administration of vitamin K and clotting factors in managing a warfarin induced bleed?

A
  • Vitamin K - 6 hours
  • Clotting factors - immediate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name an example of a direct thrombin inhibitor

A

Dabigatran - targets thrombin

17
Q

Name examples of activated factor X inhibitors

A

Rivaroxaban + apixaban

18
Q

What is the benefit of these new anticoagulants?

A
  • Oral and no monitoring required
  • Less drug interactions
  • Currently no specific antidote for reversal
19
Q

What are these new anticoagulants e.g. apixaban and dabigatran used for?

A
  • Used instead of LMWH as prophylaxis in elective hip and knee replacment surgery
  • Used for selected patients for stroke prevention in atrial fibrillation
  • Used for treatment of DVT/PE
20
Q

What is atherosclerosis?

A
  • Not the same as arterial thrombosis
  • Damage to endothelium
  • Recruitment of foamy macrophages rich in cholesterol
  • Forms plaques rich in cholesterol
21
Q

Describe stable atherosclerotic plaques and give examples of what conditions they are seen in

A
  • Hyalinsed and calcified
  • Stable plaques are seen in angina and intermittent claudication
22
Q

Describe unstable atherosclerotic plaques and give examples of what conditions they are seen in

A
  • Plaques rupture, platelets are recruited and cause acute thrombosis
  • Sudden onset of symptoms
  • Unstable angina or myocardial infarction (coronary arteries)
  • Stroke (cerebral arteries)
23
Q

Describe the relationship between platelets and arterial thrombosis

A
  • Plaque ruptures (more liklely in arteries due to high pressure)
  • Platelet adheres to it - exposed endothelium and release of VWF
  • Platelets become activated - release granules that active coagulation and recruit other platelets to developing platelet plug
  • Platelet aggregation via membrane glycoproteins
24
Q

What are some risk factors for arterial thombosis?

A

Factors that cause damage to the endothelium, increase in foamy macrophages and platelet activation

  • Hypertension - damage to endothelium, platelet activation
  • Smoking - endothelium, platelets
  • High cholesterol - accumulated in plaque
  • Diabetes mellitus - endothelium, platelets, cholesterol
25
Q

What is the adhesion stage of formation of the platelet plug?

A

Platelets bind to subendothelial collagen via glycoprotein 1b and VWF

26
Q

What is the aggregation stage of platelet plug formation?

A

Platelets attach to each other via glycoprotein IIb, IIIa and fibrinogen

27
Q

What is the activation stage of platelet plug formation?

A
  • Platelets alter their shape to expose more phospholipid on the surface - provides a greater surface area for coagulation activation and fibrin production to stabilise the clot
  • Process is augmented by release of granules that further stimulate platelet activation e.g. thrombin, thromboxane A2 and ADP in order to recruit more platelets to the process
  • This occurs via receptors to ADP etc. on the platelet surface
28
Q

What is the mechanism of action of aspirin?

A

Inhibits cyclo-oxygenase which is necessary to produce thromboxane A2 (a platelet agonist released from granules on activation)

29
Q

What are some of the side effects associated with aspirin?

A
  1. Bleeding
  2. Blocks prostaglandin prodution –> GI ulceration and bronchospasm
30
Q

Name some examples of ADP receptor antagonists

A

Clopidogrel, prasugrel

31
Q

What is the mechanism of action of dipyridamole?

A

Phosphodiesterase inhibitor - reduced production of cAMP which is a second messenger in platelet activation

32
Q

Name an example of a glycoprotein IIb/IIIa inhibitor

A

Abciximab - inhibits aggregation of platelets

33
Q

How long do anti-platelets need to be stopped prior to surgery?

A
  • Anti-platelets tend to affect platelet function for their 7-10 day life span
  • Stop anti-platelet agents 7 days prior to elective operations
  • If serious bleeding - can reverse with platelet transfusion
34
Q

Platelets are central in venous thrombosis and are recrutied to ruptured plaques. Antiplatlet drugs are thus useful in preventing venous thrombosis. T/F?

A

False - platelets are central in arterial thrombosis and are recruited to ruptured plaques. Platelets are NOT largely involved in venous thrombosis and clots are rich in fibrin. Antiplatelet drugs are useful in preventing arterial thrombosis whilst anticoagulant drugs are useful in prevention of venous thrombosis.